Author

Jianping He

University of Notre DameORCID 0009-0001-6177-4179Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

Zachary T. SchaferiD· 2 shared Adrian ChaoiD· 1 shared Andrii BaliaiD· 1 shared Cristina CastilloiD· 1 shared Elizabeth C. McCullaiD· 1 shared Éva SzegezdiiD· 1 shared Guoqiang LiuiD· 1 shared Hannah Noelle BelliD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Zachary T. SchaferORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedJul 1, 2026

Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma

Xuechun Wang, Yujing Qin, Loan Duong…·Éva Szegezdi

This study identifies TRAIL as a synthetic essentiality in VHL-deficient ccRCC, showing its regulation by HIF2 and its role in cell proliferation through the p38 MAPK pathway, suggesting a combination therapy strategy.

DOI 10.1073/pnas.2535452123

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCancer ResearchPeer-reviewedMay 19, 2025

Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer

Stephen L. DeAngelo, Liang Zhao, Sofia Dziechciarz…·Yatrik Madhukar Shah

This study recharacterizes RSL3 as a broad selenoprotein inhibitor, showing its potential as a therapeutic target for colorectal cancer by inducing ferroptosis.

39 citationstop 1%

humanproteomics

𝕏 PostBluesky